Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 63845R107 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Dimensional Fund Advisors LP 13G | 5.1% |
10/8/2026
Event 9/30/2026
|
|
|
Wellington Management Group LLP
13G/A
Amendment 2
|
9.6% |
8/13/2026
Event 6/30/2026
|
|
| Wellington Management Group LLP | 9.6% | ||
| Wellington Group Holdings LLP | 9.6% | ||
| Wellington Investment Advisors Holdings LLP | 9.6% | ||
| Wellington Management Company LLP | 7.9% | ||
|
Wellington Management Group LLP
13G/A
Amendment 3
|
10.4% |
8/6/2026
Event 7/31/2026
|
|
| Wellington Management Group LLP | 10.4% | ||
| Wellington Group Holdings LLP | 10.4% | ||
| Wellington Investment Advisors Holdings LLP | 10.4% | ||
| Wellington Management Company LLP | 8.6% | ||
|
FMR LLC
13G
|
5.1% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 5.1% | ||
| Abigail P. Johnson | 5.1% | ||
| Vanguard Capital Management LLC 13G/A Amendment 1 | 4.98% |
7/31/2026
Event 6/30/2026
|
|
| Vanguard Capital Management LLC 13G | 5.1% |
4/30/2026
Event 3/31/2026
|
|
| Vanguard Portfolio Management LLC 13G | 7.3% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 9 | 0% |
3/27/2026
Event 3/13/2026
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
4.5% |
2/13/2026
Event 12/31/2025
|
|
| American Century Investment Management, Inc. | 4.5% | ||
| American Century Companies, Inc. | 4.5% | ||
| Stowers Institute for Medical Research | 4.5% | ||
|
Wellington Management Group LLP
13G/A
Amendment 1
|
7.3% |
2/10/2026
Event 12/31/2025
|
|
| Wellington Management Group LLP | 7.3% | ||
| Wellington Group Holdings LLP | 7.3% | ||
| Wellington Investment Advisors Holdings LLP | 7.3% | ||
| Wellington Management Company LLP | 6.1% | ||
| Fund 1 Investments, LLC 13G/A Amendment 1 | 0.5% |
11/14/2025
Event 9/30/2025
|
|
|
American Century Investment Management, Inc.
13G
|
5.6% |
11/14/2025
Event 9/30/2025
|
|
| American Century Investment Management, Inc. | 5.6% | ||
| American Century Companies, Inc. | 5.6% | ||
| Stowers Institute for Medical Research | 5.6% | ||
| William Blair Investment Management, LLC 13G | 6.2% |
11/12/2025
Event 9/30/2025
|
|
|
Wellington Management Group LLP
13G
|
5.7% |
11/12/2025
Event 9/30/2025
|
|
| Wellington Management Group LLP | 5.7% | ||
| Wellington Group Holdings LLP | 5.7% | ||
| Wellington Investment Advisors Holdings LLP | 5.7% | ||
| BlackRock, Inc. 13G/A Amendment 5 | 14.4% |
10/17/2025
Event 9/30/2025
|
|
| Burgundy Asset Management Ltd. 13G/A Amendment 1 | 3.2% |
8/13/2025
Event 6/30/2025
|
|
| Fund 1 Investments, LLC 13G | 5.7% |
5/15/2025
Event 3/31/2025
|
|
| BlackRock, Inc. 13G/A Amendment 4 | 15.4% |
4/28/2025
Event 3/31/2025
|
|
| Burgundy Asset Management Ltd. 13G | 5.9% |
2/13/2025
Event 12/31/2024
|
|
| Clearbridge Investments, LLC 13G/A Amendment 3 | 0% |
10/31/2024
Event 9/30/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 5 | 11.7 k | $191 k |
| 2026 Q2 | 246 | 102 M | $1.99 B |
| 2026 Q1 | 269 | 95.4 M | $2.47 B |
| 2025 Q4 | 270 | 92.9 M | $2.40 B |
| 2025 Q3 | 282 | 90.8 M | $2.65 B |
| 2025 Q2 | 270 | 87.7 M | $2.02 B |
| 2025 Q1 | 230 | 84.7 M | $1.08 B |
| 2024 Q4 | 200 | 81.1 M | $845 M |
| 2024 Q3 | 215 | 79.3 M | $865 M |
| 2024 Q2 | 204 | 89.1 M | $1.17 B |
| 2024 Q1 | 211 | 89.1 M | $1.97 B |
| 2023 Q4 | 211 | 88.3 M | $1.85 B |
| 2023 Q3 | 210 | 79.9 M | $1.29 B |
| 2023 Q2 | 201 | 84.7 M | $2.06 B |
| 2023 Q1 | 195 | 84.0 M | $1.58 B |
| 2022 Q4 | 206 | 96.6 M | $3.74 B |
| 2022 Q3 | 206 | 99.2 M | $3.24 B |
| 2022 Q2 | 184 | 99.7 M | $2.74 B |
| 2022 Q1 | 191 | 97.0 M | $4.25 B |
| 2021 Q4 | 198 | 94.6 M | $4.53 B |
| 2021 Q3 | 204 | 94.5 M | $5.37 B |
| 2021 Q2 | 202 | 93.3 M | $4.77 B |
| 2021 Q1 | 213 | 92.7 M | $4.07 B |
| 2020 Q4 | 210 | 96.2 M | $4.36 B |
| 2020 Q3 | 183 | 94.7 M | $3.63 B |
| 2020 Q2 | 172 | 94.6 M | $2.89 B |
| 2020 Q1 | 163 | 86.6 M | $1.69 B |
| 2019 Q4 | 168 | 89.4 M | $2.90 B |
| 2019 Q3 | 180 | 87.7 M | $2.12 B |
| 2019 Q2 | 180 | 88.2 M | $2.72 B |
| 2019 Q1 | 159 | 85.4 M | $2.69 B |
| 2018 Q4 | 157 | 83.6 M | $2.36 B |
| 2018 Q3 | 158 | 79.9 M | $3.61 B |
| 2018 Q2 | 101 | 76.4 M | $2.79 B |
| 2018 Q1 | 103 | 74.8 M | $2.42 B |
| 2017 Q4 | 87 | 72.8 M | $2.96 B |